William Blair & Company’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

William Blair & Company’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,029	Closed	-$380K	–	1864
2023 Q2	$380K	Sell	9,029 -1,652	-15%	-$66.8K	﹤0.01%	1156
2023 Q1	$380K	Sell	10,681 -1,443	-12%	-$52.4K	﹤0.01%	1143
2022 Q4	$445K	Sell	12,124 -1,954	-14%	-$77.2K	﹤0.01%	1079
2022 Q3	$664K	Sell	14,078 -550	-4%	-$35.5K	﹤0.01%	953
2022 Q2	$1.05M	Sell	14,628 -631	-4%	-$46.1K	﹤0.01%	832
2022 Q1	$1.24M	Sell	15,259 -5,064	-25%	-$428K	﹤0.01%	843
2021 Q4	$2.09M	Buy	+20,323	New	+$1.95M	0.01%	719
2021 Q2	–	Sell	-4,266	Closed	-$324K	–	1945
2021 Q1	$324K	Buy	+4,266	New	+$322K	﹤0.01%	1300
2019 Q3	–	Sell	-3,921	Closed	-$200K	–	1772
2019 Q2	$200K	Buy	+3,921	New	+$183K	﹤0.01%	1308

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

William Blair & Company's SYNH Position: Q3 2023 in Review

William Blair & Company sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 9,029 shares — an estimated $380K sold.

William Blair & Company first reported a position in SYNH in Q2 2019 and held it in 9 quarters. The position peaked at $2.09M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

William Blair & Company reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
William Blair & Company sold 9,029 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $380K.
William Blair & Company first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2019 and held it in 9 quarters.
William Blair & Company's Syneos Health, Inc. Class A Common Stock position peaked at $2.09M in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on William Blair & Company's 13F filing for Q3 2023, filed 9 Nov 2023.